Build the future of cancer care at GSK Oncology
With a growing oncology portfolio and pipeline, GSK is expanding beyond blood and gynecological cancers into lung, gastrointestinal, prostate and other solid tumors. It's an exciting time to join a team that's combining science, technology and talent to help redefine what's possible in cancer care.

Science in action
At GSK Oncology, our teams are advancing innovative research across blood cancers, gynecologic cancers, immuno-oncology and an expanding range of solid tumors. From discovery and development to medical affairs and commercialization, employees can help bring cutting-edge science to patients while contributing to the continued growth of our oncology portfolio and pipeline.
GSK ONCOLOGY
Where we’re growingWhy this is an exciting moment to join us?

GSK oncology is experiencing growth across our research, development and commercial organizations. As our oncology portfolio and pipeline continue to grow, so do opportunities for talented people to help shape the future of cancer care. We're investing in new science, entering new disease areas and building capabilities that can help us reach more patients than ever before.
Roles across oncology space
Our growth is creating opportunities across the entire oncology value chain, from early research through commercialization and patient engagement.
If you’re an expert in one of the fields below, we have a role for you. Our vacancies regularly include opportunities for:
-Commercial leadership -Health economics and outcomes research
-Scientific leadership -Clinical development
-Sales and marketing -Quality
-Medial affairs -Drug development
-Insights and analytics -Supply chain
-Physicians -Regulatory affairs
Why GSK?
GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world by the end of the decade.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves - feeling welcome, valued and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us on this exciting moment in our journey.



